Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that the extraordinary general meeting of shareholders ("EGM") scheduled for 9 September 2013, that was convened by the company's minority shareholder Salveo Holding S.A. ("Salveo") in breach of the 180-day response time that Cryo-Save's board of directors invoked, has been adjourned by court order.
The Enterprise Chamber (Ondernemingskamer) of the Amsterdam Court of Appeal confirmed in the decision it handed down today that Cryo-Save's invocation of the 180-day response time was justified and that Salveo was not entitled to breach the response time. Consequently, the Enterprise Chamber by way of injunctive relief adjourned the EGM convened by Salveo to 20 November 2013, being the final day of the response time, or to such earlier date as the response time may be ended by Cryo-Save.
Cryo-Save will keep its shareholders and other stakeholders informed of significant developments and will issue additional statements if and when appropriate.
Enquiries:
| Cryo-Save Group | + 31 (0)575 509 100 |
| Walter van Pottelberge, Chairman |
About Cryo-Save (www.cryo-save.com/group)
Cryo-Save, the leading international family stem cell bank, stores more than 250,000 samples from umbilical cord blood and cord tissue. There are already many diseases treatable by the use of stem cells, and the number of treatments will only increase. Cryo-Save has cryopreserved samples from over 70 countries on six continents, with ultra-modern processing and storage facilities in Belgium, Germany, Dubai, India and South Africa.
